Evidence map›Paper›PMID 10595552›Full record

ArticleProtein science : a publication of the Protein Society1999

Purification and characterization of a cobalt-activated carboxypeptidase from the hyperthermophilic archaeon Pyrococcus furiosus.

T C Cheng, V Ramakrishnan, S I Chan

Open access · greenAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. From Data Mining ofMicroorganisms · 2021
    Article
  3. Article
  4. A proposed role for Leishmania major carboxypeptidase in peptide catabolism.Biochemical and biophysical research communications · 2008
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

T C ChengNoyes Laboratories, Division of Chemistry and Chemical Engineering, California Institute of Technology, Pasadena 91125, USA.
V Ramakrishnan
S I Chan
California Institute of Technology · USInstitute of Chemistry, Academia Sinica · TW

Funding

STUDIES OF LIPID-LIPID AND LIPID-PROTEIN INTERACTIONSR01GM022432 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI CHAN, SUNNEY I. · 1985 to 1989
–
MEMBRANE PROTEIN--STRUCTURE AND FUNCTIONR37GM022432 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI CHAN, SUNNEY I. · 1990 to 1999
–
PROTEIN SEQUENATOR AND TOF MASS SPECTROMETERS10RR011292 · NCRR · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI KENNEDY, MARY B · 1996 to 1996
–
NCRR NIH HHS RR11292NIGMS NIH HHS GM 22432
6 · The paper itself

Abstract

A novel metallocarboxypeptidase (PfuCP) has been purified to homogeneity from the hyperthermophilic archaeon, Pyrococcus furiosus, with its intended use in C-terminal ladder sequencing of proteins and peptides at elevated temperatures. PfuCP was purified in its inactive state by the addition of ethylenediaminetetraacetic acid (EDTA) and dithiothreitol (DTT) to purification buffers, and the activity was restored by the addition of divalent cobalt (K, = 24 +/- 4 microM at 80 degrees C). The serine protease inhibitor phenylmethylsulfonyl fluoride (PMSF) had no effect on the activity. The molecular mass of monomeric PfuCP is 59 kDa as determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) and 58 kDa by SDS-PAGE analysis. In solution, PfuCP exists as a homodimer of approximately 128 kDa as determined by gel filtration chromatography. The activity of PfuCP exhibits a temperature optimum exceeding 90 degrees C under ambient pressure, and a narrow pH optimum of 6.2-6.6. Addition of Co2+ to the apoPfuCP at room temperature does not alter its far-UV circular dichroism (CD) or its intrinsic fluorescence spectrum. Even when the CoPfuCP is heated to 80 degrees C, its far-UV CD shows a minimal change in the global conformation and the intrinsic fluorescence of aromatic residues shows only a partial quenching. Changes in the intrinsic fluorescence appear essentially reversible with temperature. Finally, the far-UV CD and intrinsic fluorescence data suggest that the overall structure of the holoenzyme is extremely thermostable. However, the activities of both the apo and holo enzyme exhibit a similar second-order decay over time, with 50% activity remaining after approximately 40 min at 80 degrees C. The N-blocked synthetic dipeptide, N-carbobenzoxy-Ala-Arg (ZAR), was used in the purification assay. The kinetic parameters at 80 degrees C with 0.4 mM CoCl2 were: Km, 0.9 +/- 0.1 mM; Vmax, 2,300 +/- 70 U mg(-1); and turn over number, 600 +/- 20 s(-1). Activity against other ZAX substrates (X = V, L, I, M, W, Y, F, N, A, S, H, K) revealed a broad specificity for neutral, aromatic, polar, and basic C-terminal residues. This broad specificity was confirmed by the C-terminal ladder sequencing of several synthetic and natural peptides, including porcine N-acetyl-renin substrate, for which we have observed (by MALDI-TOF MS) stepwise hydrolysis by PfuCP of up to seven residues from the C-terminus: Ac-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Val-Tyr-Ser.

Indexed as

Archaeal ProteinsAmino Acid SequenceCarboxypeptidasesChromatography, GelChromatography, Ion ExchangeCobaltDithiothreitolEdetic AcidElectrophoresis, Polyacrylamide GelEnzyme ActivationKineticsMacromolecular SubstancesMolecular Sequence DataMolecular WeightProtein ConformationPyrococcus furiosusArchaeal ProteinsCarboxypeptidasesCobaltDithiothreitolEdetic AcidMacromolecular SubstancesPfuCP carboxypeptidase, Pyrococcus furiosus

Identifiers

PMID10595552
PMCPMC2144183
OpenAlexW1984938219

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.